Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide‐induced inflammatory cystitis

@article{Chuang2011IntravesicalIS,
  title={Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide‐induced inflammatory cystitis},
  author={Yao-Chi Chuang and Pradeep Tyagi and Hsuan-Ying Huang and Naoki Yoshimura and Moya Wu and Jonathan Kaufman and Michael B. Chancellor},
  journal={Neurourology and Urodynamics},
  year={2011},
  volume={30}
}
Potent immunosuppressive effect of tacrolimus has encouraged its topical application for achieving local anti‐inflammatory effect. However, its poor aqueous solubility presents challenges in formulating biocompatible instillations to justify the investigation of liposomes as vehicle for tacrolimus. 
View on Wiley
lipella.com
37 Citations
Background Citations
11
Methods Citations
2

37 Citations

Citation Type

Citation Type

Intravesical administration of blebbistatin prevents cyclophosphamide‐induced toxicity of the urinary bladder in female Wistar rats
The main goal of our study was to investigate whether blebbistatin would prevent the cyclophosphamide (CYP)‐induced changes in cystometric and inflammatory parameters indicating the development of…
Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome – A pilot study
TLDR
The purpose of this pilot study was to find if tacrolimus instilled in bladder is effective in treating BPS/IC without side effects.
Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure.
Role of liposome in treatment of overactive bladder and interstitial cystitis
Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
TLDR
This review will present new developments on instillations of liposomes and liposome-encapsulated drugs into the urinary bladder for treating lower urinary tract dysfunction.
Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis
TLDR
An 81-year-old man with a history of localized prostate cancer, which was treated with external beam radiation therapy and subsequently developed severe hemorrhagic radiation cystitis, is presented with the novel use of intravesical tacrolimus for the treatment of refractory radiation Cystitis and gross hematuria.
Intravesical liposome drug delivery and IC/BPS
TLDR
This review considers the current status of intravesical LPs and LP mediated drug delivery for the treatment of interstitial cystitis/bladder pain syndrome.
Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide‐induced haemorrhagic cystitis
TLDR
The roles of chemokine receptor 2 (CXCR2) and transient receptor potential vanilloid 1 (TRPV1) channels are investigated in a rat model of cyclophosphamide‐induced cystitis.
Intravesical liposome therapy for interstitial cystitis
TLDR
The present review discusses the properties of liposomes that are important for their intrinsic therapeutic effect, summarizes the recently completed clinical studies with intravesical liposome and covers the latest developments in this field.
Chemotherapy-induced hemorrhagic cystitis: pathogenesis, pharmacological approaches and new insights -
TLDR
The purpose of this review is to examine the current knowledge regarding the pathogenesis of HC, describing the importance of transcription factors, cytokines, and enzymes, among other mediators, for the bladder injury.
...
1
2
3
4
...

References

SHOWING 1-10 OF 29 REFERENCES
Liposomal tacrolimus lotion as a novel topical agent for treatment of immune‐mediated skin disorders: experimental studies in a murine model
TLDR
Systemic but not topical tacrolimus (TAC) is effective against psoriasis, but mechanical methods that enhance skin penetration by TAC increase its topical antipsoriatic effect.
Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation
TLDR
Tac was significantly more effective than CyA microemulsion in preventing acute rejection after renal transplantation in a pediatric population and the overall safety profiles of the two regimens were comparable.
Cyclophosphamide: ovarian and other toxicities
TLDR
With projections that millions of dollars are saved annually through the delay or prevention of hemodialysis or renal transplantations, reservations about cyclophosphamide involve concerns as to the potential for serious toxicities from the drug.
Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study.
Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat.
CXCL10 blockade protects mice from cyclophosphamide-induced cystitis
TLDR
The present study is among the first to demonstrate some of the cellular and molecular mechanisms of chemokines in cystitis and may represent new drug target for this disease.
The use of prostaglandin F2 alpha for the prophylaxis of cyclophosphamide induced cystitis in rats.
FK 506-mediated T-cell apoptosis induction.
Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus.
...
1
2
3
...